Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06957756) titled 'A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems' on May 2.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Boehringer Ingelheim

Condition: Hepatic Insufficiency

Intervention: Drug: BI 1584862...

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: June 27, 2025

Target Sample Size: 32

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06957756

Published by HT Digital Content Services with pe...